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Abstract Inorganic phosphate (Pi) reabsorption in the
renal proximal tubule occurs mostly via the Na+/Pi
cotransporter type IIa (NaPi-IIa) located in the brush-
border membrane (BBM) and is regulated, among other
factors, by dietary Pi intake and parathyroid hormone
(PTH). The PTH-induced inhibition of Pi reabsorption is
mediated by endocytosis of Na/Pi-IIa from the BBM and
subsequent lysosomal degradation. Megalin is involved in
receptor-mediated endocytosis of proteins from the urine
in the renal proximal tubule. The recently identified
receptor-associated protein (RAP) is a novel type of
chaperone responsible for the intracellular transport of
endocytotic receptors such as megalin. Gene disruption of
RAP leads to a decrease of megalin in the BBM and to a
disturbed proximal tubular endocytotic machinery. Here
we investigated whether the distribution of NaPi-IIa and/
or its regulation by dietary Pi intake and PTH is affected
in the proximal tubules of RAP-deficient mice as a model
for megalin loss. In RAP-deficient mice megalin expres-
sion was strongly reduced and restricted to a subapical
localization. NaPi-IIa protein distribution and abundance
in the kidney was not altered. The localization and
abundance of the NaPi-IIa interacting proteins MAP17,
PDZK-1, D-AKAP2, and NHE-RF1 were also normal.
Other transport proteins expressed in the BBM such as the
Na+/H+ exchanger NHE-3 and the Na+/sulphate cotrans-
porter NaSi were normally expressed. In whole animals
and in isolated fresh kidney slices the PTH-induced
internalization of NaPi-IIa was strongly delayed in RAP-
deficient mice. PTH receptor expression in the proximal
tubule was not affected by the RAP knock-out. cAMP,
cGMP or PKC activators induced internalization which
was delayed in RAP-deficient mice. In contrast, both
wildtype and RAP-deficient mice were able to adapt to
high-, normal, and low-Pi diets appropriately as indicated
by urinary Pi excretion and NaPi-IIa protein abundance.
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Introduction
Phosphate reabsorption in the renal proximal tubule
occurs mostly via the secondary active sodium phosphate
cotransporter type IIa (NaPi-IIa) [16]. NaPi-IIa transport
activity is regulated by a variety of hormonal and non-
hormonal factors [16]. One of the major regulating factors
is parathyroid hormone (PTH) that induces phosphaturia
by inducing brush-border membrane (BBM) Na/Pi-co-
transporter internalization and subsequent lysosomal
degradation [15, 16, 20]. Recent studies have shown that
this process requires endocytosis of Na/Pi-cotransporter
proteins from the BBM. Internalization of NaPi-IIa most
likely occurs at the invaginated membrane regions at the
base of the brush border membrane [23]. Internalized
NaPi-IIa proteins are subsequently directed to the lyso-
somes for degradation [20, 23].
Megalin, a 600-kDa membrane protein belonging to
the LDL receptor family, is strongly involved in the
endocytotic pathway of renal proximal tubules [5, 7, 8,
18, 25, 29]. Megalin expression is found in the BBM, at
the base of the microvilli and throughout much of the
subapical endocytotic apparatus [7, 8, 9] where NaPi-IIa
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protein is also localized [23]. In the proximal tubule
megalin serves as a receptor in the brush border
membrane for endocytosis of a variety of hormones and
endogenous or exogenous substances [8, 9]. Reduction or
loss of megalin expression and function is associated in
mice models and patients (Fanconi type syndromes) with
loss of vitamin D3, albumin, and other smaller proteins
into the urine resulting in the disturbance of whole body
calcium homeostasis and bone development [7, 8, 17, 18,
19, 29). Moreover, megalin has been shown to interact
with parathyroid hormone and is able to inactivate PTH,
thus, controlling PTH activation of PTH receptors [12]. In
addition to its role in endocytosis of proteins from the
urine, it has been suggested that megalin may directly
interact with proteins in the brush border membrane such
as the Na+/H+-exchanger NHE-3 and may be important
for the regulation and expression of this protein by
mediating its endocytosis and membrane recycling [4].
The recently identified receptor-associated protein
(RAP) is a novel type of chaperone involved in the
biosynthesis and intracellular transport of endocytotic
receptors of the LDL family, among others megalin [5,
27, 29]. RAP binds to megalin competing with its
intracellular ligands and thereby prevents premature
targeting to the lysosome and degradation [28]. Gene
disruption experiments of RAP demonstrated a reduction
and redistribution of megalin in the BBM and a disturbed
proximal tubular endocytotic machinery [5]. Hence, RAP
serves an important function in the normal renal expres-
sion and subcellular distribution of megalin. RAP-
deficient mice are relatively healthy compared to me-
galin-deficient mice and can thus serve as a model for
megalin loss in adult animals. This prompted us to use
RAP-deficient mice to investigate whether the distribu-
tion of NaPi-IIa and/or its regulation by PTH and dietary
phosphate intake is affected in proximal tubules by loss of
RAP/megalin.
Materials and methods
Animal studies
Experiments were performed with age matched, male, wildtype
mice (RAP+/+) and RAP knockout mice (RAP/)(Jackson
Laboratory, Maine, USA) weighing between 20–25 g (RAP+/+)
and 15–20 g (RAP/). The RAP knockout mice were deficient for
the low-density RAP 1 and bred in the C57BL/6 J background [27].
Mice were kept on a standard laboratory diet and had free access to
food and water. For some experiments the mice received diets
(Kliba, NAFAG, Switzerland) with a high (1.2%) or low (0.1%) Pi
content as described previously [13].
Spontaneous urine samples were collected daily at the same
time and rapidly frozen until analysis. All samples were analyzed
for Pi and creatinine using commercial kits (Sigma) according to
the protocol provided by the manufacturer.
Injection of PTH and FITC-dextran
Mice were anaesthetized with a combination of ketamine (Narketan
10, Chassot, Belp, Switzerland) and xylazine (Rompun, Bayer,
Leverkusen, Germany), injected intraperitoneally (i.p.). 1–34 PTH
(25 mg/animal, dissolved in 0.9% saline) and/or 10-kDa FITC-
dextran (2.5 mg/animal, dissolved in 0.9% saline) were injected
into the tail vein as a single bolus (100 ml). Animals from the
control group were injected with 100 ml of 0.9% saline alone.
Twenty minutes after injection urine was collected from the urinary
bladder and the animals were fixed by intravascular perfusion via
the abdominal aorta at a pressure of 1.38 hp as described previously
[10]. The fixative consisted of 3% paraformaldehyde and 0.05%
picric acid. It was dissolved in a 3:2 mixture of 0.1 M cacodylate
buffer (pH 7.4, adjusted to 300 mosmol with sucrose) and 10%
hydroxyethyl starch in saline (HAES-steril, Fresenius, Stans,
Switzerland). After 5 min of fixation the kidneys were rinsed for
5 min with the 0.1 M cacodylate buffer. Thin tissue slices (1–2 mm
thick) were mounted on small cork disks, frozen in liquid propane
and stored at 80C until use.
Detection of FITC-dextran
The relative amount of FITC-dextran in the collected urine was
measured with a spectrofluorometer at an excitation wavelength of
488 nm and an emission wavelength of 520 nm. The resulting
fluorescence was expressed in arbitrary units.
Kidney slices
For kidney slice experiments mice were kept on a low-phosphate
diet for 5 days prior to the experiments to increase NaPi-IIa
expression in kidney [13]. The mice were anaesthetized (i.p.) and
perfused through the left ventricle with 50 ml warm (30C) sucrose/
phosphate buffer (140 mM sucrose, 140 mM NaH2PO4/NaH2PO4,
pH 7.4) to remove all blood from the kidneys. Kidneys were rapidly
harvested, adhering connective tissue and extrarenal vessels were
removed, and thin coronal slices (about 1 mm in thickness) were
prepared. From each kidney six to seven slices could be prepared.
Slices were transferred into 4 ml of pre-warmed (37C) Hank’s
buffer [6] (NaCl 110 mM, KCl 5 mM, MgSO4 1.2 mM, CaCl2
1.8 mM, Na-acetate 4 mM, Na-citrate 1 mM, glucose 6 mM, l-
alanine 6 mM, NaH2PO4 1 mM, Na2HPO4 3 mM, NaHCO3 25 mM,
pH 7.4, gassed with 5% CO2 and 95% O2) and allowed to adapt for
10 min at 37C in a water bath prior to the start of the incubation.
Slices were then left untreated (control) or incubated with PTH, 8-
Br-cAMP, 8-Br-cGMP, or 1,2-dioctanoyl-sn-glycerol (DOG). Dur-
ing the whole course of the experiments all solutions were gassed
with 5% CO2/ 95% O2 and the pH was kept constant at 7.4€0.1. We
have previously shown that the kidney slices/proximal tubule cells
retain major morphological characteristics during the incubation
time and are responsive to several hormonal treatments demon-
strating their viability [2].
All chemicals were obtained from Sigma Chemical (St. Louis,
Mo., USA). All experiments were performed at least with two
kidneys from two different animals. Untreated slices were used in
all experiments as an internal control. For immunohistochemistry,
kidney slices were transferred to a fixation solution at the end of the
incubation. The same fixative was used as for the in vivo
experiments. Slices were fixed for 4 h on ice. After fixation, slices
were rinsed few times with PBS, mounted onto thin cork plates and
immediately frozen in liquid propane, cooled with liquid N2.
Immunohistochemistry
For immunofluorescence staining, sections (3–5 mm thick) were cut
in a cryostat and placed on chrome alum gelatine-coated glass
slides. For NaPi-IIa and MAP17 immunofluorescence sections were
pretreated for 10 min in PBS containing 3% defatted milk powder
and 0.02% Triton X-100 ("blocking solution") to block nonspecific
binding of antibody. Immunostaining was carried out as described
previously [10]. Briefly, sections were incubated with an anti-rat
NaPi-IIa rabbit antiserum diluted 1:500, rabbit anti MAP17
antibody diluted 1:1,000 or anti-megalin Ab (kind gift of Dr. Ziak
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and Dr. Roth, Institute of Pathology, University of Zurich) diluted
1:10,000, respectively. For PTH receptor, NHE-3, and NHERF-1
staining sections were pretreated with 0.5% SDS in PBS for 5 min.
After repeated rinsing with PBS sections were incubated for 10 min
with blocking solution. Sections were then incubated with an
affinity-purified polyclonal antibody against PTH receptor (Cov-
ance Research Products, USA) at a dilution of 1:50, with polyclonal
anti-rat NHE3 antibody (kindly provided by Dr. Orson W. Moe,
University of Texas Southwestern Medical Center, Dallas, Tex.,
USA) at a dilution of 1:1,000, or with affinity-purified anti-NHE-
RF1 antiserum (kindly provided by E. Weinman, Baltimore, Md.,
USA) diluted 1:200. In the case of D-AKAP-2 and PDZK1 sections
were microwaved in buffer containing 0.01 M citrate in distilled
water at low power for 10 min. After rinsing with PBS and covering
for 10 min with “blocking” solution, sections were incubated with
polyclonal antibodies against rabbit D-AKAP2 (rabbit) (Gisler,
Pribanic, Bacic, Sabourin, Tsuji, Manser, Biber, and Murer,
unpublished results) diluted 1:1,000 or with an anti-PDZK1
antibody [11] diluted 1:500. All primary antibodies were diluted
in “blocking solution” and incubated over night at 4C. Sections
were then rinsed three times with PBS and covered for 40 min at
room temperature in the dark with FITC-conjugated swine anti-
rabbit IgG (Dakopatts, Glostrup, Denmark) diluted 1:50 in PBS/
milk powder. Double stainings of NaPi-IIa and b-actin filaments
were achieved by adding rhodamine-phalloidin (Molecular Probes,
Eugene, Ore., USA), respectively, at a dilution 1:50 in the solution
containing secondary antibodies. Finally, the sections were rinsed
three times with PBS, covered with a glass-slip using DAKO-
Glicergel (Dakopatts) containing 2.5% 1,4-diazabicyclo [2.2.2.]
octane (Sigma, St. Louis, Mo., USA) as a fading retardant, and
studied with an epifluorescence microscope. Unspecific binding to
the tissue of the secondary antibodies was assessed by omitting the
primary antibody (data not shown). All control incubations were
clearly negative.
Western blots
For Western blotting, mice were sacrificed, the kidneys rapidly
removed, and connective tissue removed and homogenized for
2 min in an ice-cold buffer (140 mM mannitol, containing PMSF,
K-EDTA, leupeptin and statpeptin as protease inhibitors). The
tissue was then centrifuged for 15 min at 4C and at 4,500 rpm. The
supernatant was again centrifuged for 30 min at 4C at 41,000 rpm
and the pellet resuspended in the membrane preparation buffer [3].
After measurement of the total protein concentration (Biorad
Protein kit), 50 mg of total membrane protein were solubilized in
Laemmli sample buffer, and SDS-PAGE was performed on 8–15%
polyacrylamide gels. For immunoblotting, proteins were transferred
electrophoretically from gels to PVDF membranes (Immobilon-P,
Millipore, Bedford, Mass., USA). After blocking with 5% milk
powder in TRIS-buffered saline/0.1% Tween-20 for 60 min, the
blots were incubated with the primary antibodies (rabbit anti-NaPi-
IIa 1:6,000, mouse monoclonal anti-actin (42 kDa, Sigma) 1:5,000,
rabbit anti-D-AKAP2 1:5,000, rabbit anti-NHE-3 1:5,000, rabbit
anti NaSi 1:5,000, rabbit anti-MAP17 1:3,000, rabbit anti NHERF-
1 1:3,000, rabbit anti PDZK1 1:5,000) either for 2 h at room
temperature or overnight at 4C. After washing and subsequent
blocking, blots were incubated with the secondary antibodies
(donkey anti-rabbit 1:10,000 or sheep anti-mouse 1:10,000,
respectively) IgG-conjugated with horseradish peroxidase (Amers-
ham Life Sciences) for 1 h at room temperature. Antibody binding
was detected with the peroxidase/ luminal enhancer kit (Pierce,
Rockford, USA) before exposure to X-ray film (Kodak). All films
were analysed using SCION Imaging software to calculate the
protein of interest : actin ratio. All results were tested for
significance using the unpaired Student’s t-test and only results
with P<0.05 were considered as statistically significant.
Results
Immunohistochemistry using kidneys from RAP+/+ and
RAP–/– mice showed that megalin labeling in the
microvilli of the brush border was strongly reduced with
a strong signal in the subapical compartment similar to
what has been reported earlier (Fig. 1, panels A, B, a and
b) [5]. This confirms the importance of RAP for the
expression and localization of megalin. In contrast, the
localization of NaPi-IIa was comparable in both groups of
mice (Fig. 1, panels C, D, c and d). The intensity of the
NaPi-IIa immunostaining was strongest in proximal
convoluted tubules of juxtamedullary nephrons. A more
detailed view of proximal tubules of the midcortical
region (Fig. 1, panels c and d) revealed that the strongest
immunostaining for NaPi-IIa was visible in the BBM and
weaker at some intracellular sites. The overall NaPi-IIa
protein abundance was comparable in wildtype and RAP-
deficient mice as demonstrated and discussed later
(Fig. 9). Moreover, no difference in the relative abun-
dance or localization of the BBM-expressed NaSi and
Na+/H+ exchanger NHE-3 were found (Fig. 2). Recently,
a number of proteins have been identified that interact
with NaPi-IIa some of which influence its abundance,
localization and activity ([11, 22]; (Gisler, Pribanic,
Bacic, Sabourin, Tsuji, Manser, Biber, and Murer,
unpublished results). However, as shown in Fig. 3, the
localization of NHE-RF1, PDZK1, MAP 17, and D-
AKAP was not altered in kidneys from RAP-deficient
mice compared to wildtype (Fig. 3), suggesting that
disruption of RAP did not interfere with their expression
and function. Also the relative abundance of these
proteins as determined by Western blotting was not
affected (ratio NHE-RF-1/actin RAP+/+: 1.24€0.05,
RAP/: 1.37€0.13; ratio PDZK-1/ actin RAP+/+:
0.63€0.18, RAP/: 0.98€0.28; ratio MAP17/actin
RAP+/+: 0.64€0.06, RAP/: 0.80€0.14; ratio D-AKAP/
actin RAP+/+: 0.81€0.01, RAP/: 0.86€0.02, for all
conditions at least n=6 animals, repeated in triplicates).
To test for the PTH induced endocytosis of NaPi-IIa in
vivo, RAP/ and RAP+/+ mice were injected with PTH
into the tail vein and fixed by perfusion after 20 min as
described previously [23]. In wildtype animals after PTH
injection NaPi-IIa protein-specific immunofluorescence
was scarcely detectable in midcortical and superficial
regions whereas in proximal tubules of juxtamedullary
nephrons some apical expression of NaPi-IIa was still
observed (Fig. 4B). Cross-sections of midcortical proxi-
mal tubules (Fig. 4F) illustrate that NaPi-IIa immunoflu-
orescence in the BBM was decreased, whereas the
intensity of the intracellular staining was increased in
the subapical region. These data confirmed those previ-
ously published by our group [14, 23]. In contrast, in
RAP-deficient mice the PTH injection had no effect on
the intensity and distribution of NaPi-IIa staining (Fig. 4D,
H), suggesting defective PTH-induced endocytosis of
NaPi-IIa. To confirm that the PTH injection into the tail
vein had been successful, coinjections with FITC-dextran
(10 kDa) were performed and urinary FITC excretion was
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Fig. 1 Localization and expression of megalin and Na+/Pi cotrans-
porter type IIa (NaPi-IIa) in kidneys from receptor-associated
protein (RAP) wildtype (+/+) and RAP-deficient (/) mice.
Cryosections (4 mm) from the kidney cortex of wildtype (panels A,
C, a, c) and RAP-deficient (panels B, D, b, d) mice were labelled
with antibodies against megalin or NaPi-IIa. Megalin labelling is
strongly reduced in kidneys from RAP/ mice (panel B) and
shows subapical staining (panel b) in contrast to wildtype animals
where megalin is abundant (panel A) and seen throughout the entire
brush border membrane (panel a). No difference was seen for NaPi-
IIa staining between wildtype (panels C, c) and RAP-deficient mice
(panels D, d) under low-phosphate diet. Scale bars: panels A–D
~200 mm; panels a–d ~10 mm
Fig. 2A–C Expression of Na+/sulphate cotransporter (NaSi) and
the Na+/H+ exchanger NHE-3 in kidneys from RAP+/+ and RAP/
 mice. A Western blotting was performed to assess the relative
abundance of NaSi and NHE-3 in crude membrane fractions from
kidneys of wildtype (RAP+/+) and RAP-deficient (RAP/) mice.
All membranes were stripped and reprobed for actin to normalize
for loading. The ratio of NaSi or NHE-3 and actin was calculated
after densitometry to test for changes in the relative abundance. No
significant change was found for NaSi or NHE-3 (data not shown).
B Immunohistochemistry for NHE-3 demonstrated similar patterns
of labelling in kidneys from wildtype and RAP-deficient mice at
lower (A, B) or higher (panels a and b) magnification with intense
staining of the brush border membrane (BBM). Scale bars: B,
C~200 mm; panels b, c ~10 mm
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measured. Comparable amounts of FITC were found in
the urine in both RAP+/+ and RAP/ mice with similar
volumes of urine excreted (Fig. 4I). Furthermore, a
similar intensity of staining and pattern of expression of
PTH receptors on the apical and basolateral sides of
proximal tubules were observed in RAP+/+ and RAP/
mice (Fig. 5). These experiments, thus, ruled out that PTH
did not reach its target or that an altered expression of
PTH receptors in the proximal tubule could be responsible
for the lack of PTH-induced NaPi-IIa endocytosis.
In the next set of experiments we used freshly isolated
kidney slices from RAP+/+ and RAP/ mice to inves-
tigate the possibility that endocytosis may be delayed in
kidneys from RAP/ mice or that the PTH receptor may
not be functional. As shown in Fig. 6, in kidney slices
from wildtype mice (RAP+/+) incubated with 100 nM
PTH, NaPi-IIa immunostaining was strongly decreased at
all time points (45 min, 90 min, 120 min)(Fig. 6D–F)
compared to the control slices (Fig. 6A–C), whereas in
RAP-deficient mice the PTH-induced internalization was
strongly delayed (Fig. 6d–f). PTH has been shown to
activate at least two signalling cascades in proximal
tubule cells, the phospholipase C-PKC and the adenylate
cyclase-PKA pathways, both leading to internalization of
NaPi-IIa [1, 24]. In addition, the atrial natriuretic peptide
induces NaPi-IIa internalization via cGMP and PKG [1].
In order to test if a lack of activation of these pathways by
the PTH receptor may be responsible for the delayed
endocytosis of NaPi-IIa we applied 8-Br-cAMP (100 mM),
8-Br-cGMP (1 mM) or the protein kinase C activator
DOG (10 mM) for 45 min directly on the kidney slices [2,
24]. Again, internalization of NaPi-IIa was strongly
reduced in proximal tubules in kidneys from RAP-
deficient mice (Fig. 7). These results, thus, demonstrated
that endocytosis of NaPi-IIa is strongly impaired in RAP-
deficient mice. Furthermore, the fact that internalization
was even delayed after application of cAMP, cGMP or
PKC activation shows that the defect is independent of
the signalling cascade activated.
Renal phosphate reabsorption, localization and abun-
dance of the NaPi-IIa protein are strongly regulated by
dietary phosphate intake. A diet rich in phosphate induces
internalization and degradation of NaPi-IIa, whereas a
low-phosphate diet increases NaPi-IIa protein abundance
[13]. Therefore, we tested the adaptation of RAP+/+ and
RAP/ mice to high and low-phosphate diets. Basal
urinary phosphate excretion (phosphate/mg creatinine)
and reduction of phosphate excretion in response to
dietary phosphate excretion were similar in both mouse
groups (Fig. 8). Also the increase in phosphate excretion
after switching to a high-phosphate diet was not altered.
The lower mean value in the RAP/ mice was due to
two out of ten animals not responding to the high-
phosphate diet and is thus not significantly different.
Unfortunately, we were not able to determine serum
phosphate values to calculate the fractional renal excre-
tion rates of phosphate. Immunohistochemistry showed
indistinguishable NaPi-IIa abundance and localization
under both low- and high-phosphate diet (data not
shown). Also Western blotting demonstrated the ability
of RAP/ mice to adapt the abundance of NaPi-IIa
protein to the dietary phosphate intake similar to wildtype
mice. NaPi-IIa protein abundance was similar under high-
, normal and low-phosphate diet in RAP-deficient and
wildtype mice as determined by Western blotting and
calculated as NaPi-IIa/actin ratio (Fig. 9). Furthermore,
the ability of RAP/ mice to downregulate NaPi-IIa
expression in response to an acute switch from low- to
high-phosphate diet (4 h after feeding a high-phosphate
diet) was not affected as demonstrated by immunohisto-
chemistry (Fig. 10).
Fig. 3 Normal localization of proteins interacting with NaPi-IIa in
the proximal tubule. In vitro and in vivo data recently demonstrated
interaction of NHE-RF1, MAP17, PDZK-1 and D-AKAP with
NaPi-IIa. Immunohistochemical detection of NaPi-IIa-interacting
proteins in superficial kidney cortex cryosections from wildtype
(panels a, c, e, f) and RAP-deficient mice (panels b, d, f, h)
demonstrates indistinguishable subcellular localization of these
proteins mainly in the brush border membrane. Scale bar ~10 mm
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Discussion
NaPi-IIa represents the major phosphate-reabsorbing
transport system in the kidney [16]. Because of the
physiological importance of plasma phosphate levels the
activity of NaPi-IIa is tightly regulated by a variety of
factors. In general, factors decreasing renal phosphate
reabsorption, such as PTH, atrial natriuretic peptide, or
high dietary phosphate intake, lead to a downregulation of
NaPi-IIa protein abundance in the BBM by inducing
endocytosis and lysosomal degradation [16, 20, 23]. To
date, little has been known about the underlying mech-
anisms involved in the endocytotic retrieval of NaPi-IIa
transporter proteins.
In the present study we used RAP-deficient mice
which have been shown to express strongly reduced
Fig. 4A–I Lack of parathyroid
hormone (PTH)-induced NaPi-
IIa internalization in intact ani-
mals after PTH injection in
RAP-deficient mice. Saline
(0.9% NaCl) or PTH were in-
jected into the tail vein of
wildtype and RAP-deficient
mice. Mice were fixed by per-
fusion 20 min later and kidneys
stained for NaPi-IIa. In NaCl-
injected wildtype mice (A, B, E,
F) NaPi-IIa staining was stron-
gest in proximal convoluted
tubules of juxtamedullary ne-
phrons (A, E). In wildtype mice
injected with PTH (B, F)
weaker NaPi-IIa staining
demonstrates that PTH induced
internalization and degradation
of BBM NaPi-IIa. In contrast, in
RAP-deficient mice NaPi-IIa
labeling was found with the
same intensity and distribution
pattern in NaCl (C, G) or PTH
(D, H) injected animals. Scale
bars: A–D ~200 mm; E–H
~10mm. I Urinary excretion of
FITC-dextran (10 kDa) which
was coinjected with PTH or
NaCl into the tail vein. Urine
was collected from the urinary
bladder 20 min after injection
and FITC-fluorescence mea-
sured. The total urine volume
was similar in all groups
Fig. 5A, B Normal expression and localization of PTH receptors in
the proximal tubule of RAP+/+ and RAP/ mice. Immunostaining
for the PTH receptor showed indistinguishable labelling on the
apical and basolateral side of proximal tubules in both wildtype (A)
and RAP-deficient (B) mice. Scale bar ~10 mm
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amounts of megalin in the proximal tubule [5] to examine
mechanisms of NaPi-IIa regulation via endocytosis [5, 17,
18, 28]. Megalin plays an important role in the receptor-
mediated endocytosis of substances from the urine,
among them vitamin-binding protein, retinol-binding
protein, several hormones and hormone-like factors,
microglobins and calcium [7, 8, 18]. In addition, it has
been suggested that megalin may be important for the
regulation or stability of the Na+/H+ exchanger NHE-3 in
the BBM of the proximal tubule [4]. Our study is the first
demonstration of a role for megalin in the regulation of a
BBM protein, the NaPi-IIa. Two lines of evidence support
the notion that the endocytotic internalization of NaPi-IIa
is disturbed in RAP-deficient mice but not PTH sig-
Fig. 6 Delayed PTH-induced
internalization of NaPi-IIa in
isolated kidney slices in vitro.
Overview pictures over kidney
slices prepared from wildtype
(RAP+/+; upper panels A–F)
and RAP-deficient (RAP/;
lower panels a–f) mice, incu-
bated with 100 nM PTH for
several time periods, fixed, and
stained for NaPi-IIa protein. For
all time points, 45 min (panels
A, a), 90 min (panels B, b) and
120 min (panels C, c), control
and PTH-exposed slices were
obtained from the same kid-
neys. The intensity and local-
ization of NaPi-IIa
immunostaining did not change
between all three time points in
control slices of both wildtype
and RAP-deficient mice. Incu-
bation of kidney slices with
PTH induced a rapid internal-
ization of NaPi-IIa in the wild-
type and was almost complete
after 45 min (panel D), whereas
in the RAP-deficient mice in-
ternalization was delayed and
occurred only between 45 and
90 min after PTH exposure
(panels d, f). Scale bars: panels
A–F, panels a–f ~200 mm
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nalling. First, activation of internalization with pharma-
cological agents (8-Br-cAMP, 8-Br-cGMP, DOG) led to
internalization which was also delayed suggesting that not
a failure of activation of these pathways was responsible
for the delay. Interestingly, this also supports the idea that
all these pathways may converge in the same mechanism
leading to endocytotic retrieval of NaPi-IIa. Secondly, it
has recently been shown that megalin may regulate
activation of PTH receptors by antagonizing PTH [12].
Thus, a stronger or faster response to PTH would be
expected rather than a delay. In addition, we found that
the localization and relative abundance of PTH receptors
was similar in both wildtype and RAP-deficient mice.
The reduction in megalin in RAP-deficient mice seems
not to influence the steady-state expression level of NaPi-
IIa as well as of the Na+/sulphate cotransporter and the
Na+/H+ exchanger isoform 3 (NHE-3), despite its shown
interaction with megalin [4]. However, the functional
significance of the NHE-3 and megalin interaction may
need further investigation.
Presently, several questions remain to be answered. It
needs to be clarified if the reduction in megalin alone is
responsible for the observed impairment of PTH-induced
endocytosis or if other factors are also affected by RAP
deficiency. The fact that NaPi-IIa internalization was
delayed but not abolished may suggest that the residual
megalin expression was sufficient for endocytosis or that
other proteins may partially compensate. It can also not be
ruled out that loss of RAP which acts as a chaperone for
several members of the LDL-receptor family alters the
expression or function of other proteins important for
NaPi-IIa function/retrieval. Further experiments using
megalin-deficient cells or animals may help to answer
this question. Another important question is to determine
the potential molecular role of megalin in the endocytosis
of NaPi-IIa, i.e. the nature of interaction and if other
Fig. 7 Stimulation of NaPi-IIa internalization with cAMP, cGMP
and PKC activation in isolated kidney slices. Kidney slices from
wildtype (RAP+/+) and RAP-deficient (RAP/) mice were
prepared and incubated for 45 min either with control solution
(panels a, b), 8-Br-cAMP (100 mM) (panels c, d), the PKC activator
1,2-dioctanoyl-sn-glycerol (DOG) (10 mM) (panels e, f), or 8-Br-
cGMP (1 mM) (panels g, h). The sections were stained with an
antibody against NaPi-IIa (green) and with rhodamine-phalloidin
against b-actin filaments (red). Under control conditions a high
degree of overlap (yellow) between NaPi-IIa (green) and actin (red)
is seen demonstrating localization of NaPi-IIa in the brush border
membrane in both wildtype and RAP-deficient mice (panels a, b).
After the treatment with cAMP (panel c), DOG (panel e) or cGMP
(panel g), respectively, in wildtype mice NaPi-IIa cotransporter-
related fluorescence in the brush border decreases, whereas the
subapical cytoplasm shows a weak but distinct signal. In contrast,
in kidney slices from RAP-deficient mice NaPi-IIa still resides in
the BBM indicating defective internalization. The pictures were all
taken from the S1 segments of superficial nephrons. Scale bar
~10 mm
Fig. 8 Urinary phosphate excretion in response to different diets
rich or low in phosphate. Urinary phosphate excretion was
measured in ten wildtype and ten RAP-deficient mice by collecting
spot urine samples. All samples were analysed for phosphate and
normalized for creatinine excretion in the same sample. Mice
received normal diet, a diet low in phosphate (0.1%) or rich in
phosphate (1.2%). For switching to the high-phosphate diet, mice
did not receive food the night before to increase food intake. For all
time points no significant differences were found between wildtype
and RAP-deficient mice
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proteins are involved. Based on yeast-two-hybrid exper-
iments in our laboratory where we used several intracel-
lular parts of NaPi-IIa as baits we did not find any
evidence for direct megalin/NaPi-IIa interactions suggest-
ing that intermediate proteins may be involved (Gisler,
Pribanic, Bacic, Sabourin, Tsuji, Manser, Biber, and
Murer, unpublished results). Moreover, the endocytotic
pathway necessary for NaPi-IIa routing to the lysosome
will need further characterization to better understand the
regulation of proximal tubule transport proteins. Recently,
two mouse models for Dent’s disease lacking the ClC-5
channel, have been shown to suffer from reduced
endocytosis along the proximal tubule [21, 26]. Interest-
ingly, phosphaturia, reduced megalin and NaPi-IIa ex-
pression was found in ClC-5-deficient mice [21]. The
latter, however, may be due to altered renal handling of
PTH and vitamin D. If ClC-5 is also directly involved in
the regulation of NaPi-IIa retrieval is not clear to date.
In summary, we have shown PTH-induced endocytosis
is severely impaired in RAP-deficient mice which
represent a useful model for megalin deficiency. Endo-
cytosis of NaPi-IIa is delayed but not abolished, which
may be due to residual megalin expression or other
compensatory mechanisms. However, our results under-
line the significance of an intact endocytotic apparatus for
the normal regulation and internalization of an important
proximal tubule brush border membrane protein such as
NaPi-IIa.
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